Evaluation of the effect of curcumin and zinc co-supplementation on glycemic measurements, lipid profiles, and inflammatory and antioxidant biomarkers in overweight or obese prediabetic patients: a study protocol for a randomized double-blind placebo-controlled phase 2 clinical trial.
Majid KarandishHassan Mozaffari-KhosraviSeyed Mohammad MohammadiMaryam AzhdariBahman CheraghianPublished in: Trials (2020)
Iranian Registry of Clinical Trials (IRCT) IRCT20190902044671N1 . Registered on 11 October 2019.
Keyphrases
- clinical trial
- double blind
- placebo controlled
- phase ii
- phase iii
- end stage renal disease
- study protocol
- type diabetes
- oxidative stress
- ejection fraction
- weight loss
- newly diagnosed
- chronic kidney disease
- metabolic syndrome
- open label
- prognostic factors
- physical activity
- randomized controlled trial
- adipose tissue
- squamous cell carcinoma
- bariatric surgery
- anti inflammatory
- obese patients
- phase ii study
- skeletal muscle
- rectal cancer
- oxide nanoparticles